Betta Pharmaceuticals Co (SZSE:300558) Total Stockholders Equity : ¥5,522 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Total Stockholders Equity?

Betta Pharmaceuticals Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥5,522 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Betta Pharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥13.20. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Betta Pharmaceuticals Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.45.

Betta Pharmaceuticals Co Total Stockholders Equity Historical Data

The historical data trend for Betta Pharmaceuticals Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Total Stockholders Equity Chart

Betta Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

2,460.54

4,141.10

4,560.89

4,849.06

5,251.08

Betta Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															4,893.72	5,055.23	5,244.91	5,251.08	5,522.18

Betta Pharmaceuticals Co (SZSE:300558) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Betta Pharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(5522.175	-	0)	/	418.486
	=	13.20

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Betta Pharmaceuticals Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(405.167	+	2081.829)	/	5522.175
	=	0.45

Betta Pharmaceuticals Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Betta Pharmaceuticals Co (SZSE:300558) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN

Website

http://www.bettapharma.com

Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.

Executives

Wang Jia Bing	Directors, executives
Ding Lie Ming	Directors, executives
Cai Wan Yu	Executives

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines